Skip to content

Application of dexmedetomidine combined with ropivacaine to block quadrate musculi lumbosus superior arcuate ligament in laparoscopic cholecystectomy

Application of dexmedetomidine combined with ropivacaine to block quadrate musculi lumbosus superior arcuate ligament in laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400095055
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Disorders

Interventions

General anesthesia group (GA):Simple general anesthesia group
Superior arcuate ligament quadrate block group (QG group):Before general anesthesia (0.375% ropivacaine 20ml on both sides)ultrasound-guided block of the quadrate lumbus muscle of the superior arcuate
Dexmedetomidine combined with ropivacaine for superior arcuate ligament quadrate block group (DQG group):Before general anesthesia (0.375% ropivacaine combined with 0.1ug/kg dexmedetomidine 20ml on bo

Sponsors

Panzhihua Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old, American Society of Anesthesiologists (ASA) grade I.-II; 2. Laparoscopic cholecystectomy under general anesthesia; 3. Body mass index (BMI) 18-28kg/m^2; 4. Patients who are able to understand and are willing to report pain using the VAS score.

Exclusion criteria

Exclusion criteria: 1. Recent use of anticoagulant medications; 2. Allergy to the drugs used in the anesthesia process; 3. Severe cardiovascular and hematologic diseases; 4. Long-term use of opioids, sedatives, antidepressants, monoamine oxidase inhibitors and other drugs; 5. Myasthenia gravis, Parkinson's disease, or pregnancy; 6. History of previous thoracic or spinal surgery; 7. Preoperative cognitive impairment and inability to cooperate with pain assessment; 8. Local infection or systemic infection at the puncture site; 9. Failure to complete intraoperative data collection and postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
Visual analog Scale scores ;

Secondary

MeasureTime frame
Changes of heart rate and mean arterial pressure after entering the operating room (T0), after nerve block (T1), intubation time (T2), incision time (T3), after surgery (T4), and extubation time (T5);Operation time;Duration of anesthesia;Intraoperative opioid consumption;The time of the first significant pain after surgery;Time, type and dose of postoperative rescue analgesics and antiemetic drugs;Adverse reaction;Ramsay sedation evaluation;Satisfaction rating;First time out of bed activity;Length of stay;

Countries

China

Contacts

Public ContactZhu Taifang

Panzhihua Central Hospital

1738828039@qq.com+86 182 8082 8548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026